Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use
- PMID: 23066344
- PMCID: PMC3462607
Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use
Abstract
Ipilimumab (Yervoy) for metastatic melanoma
References
-
- National Cancer Institute A snapshot of melanoma. Oct, 2011. Available at: www.cancer.gov. Accessed January 16, 2012.
-
- World Health Organization Skin cancers. Available at: www.who.int/uv/faq/skincancer/en/index1.html. Accessed January 16, 2012.
-
- National Cancer Institute SEER stat fact sheets: Melanoma of the skin. Available at: http://seer.cancer.gov/statfacts/html/melan.html. Accessed January 16, 2012.
-
- National Cancer Institute Melanoma treatment (PDQ) Aug, 2011. Available at: www.cancer.gov. Accessed January 17, 2012.
-
- National Comprehensive Cancer Network NCCN practice guidelines in oncology: Melanoma (version 3.2012) Dec 1, 2011. Available at: www.nccn.com. Accessed January 16, 2012.
LinkOut - more resources
Full Text Sources
Other Literature Sources